Tang et al. studied the prognostic value of BECN1 and BRCA1 expression and found that decreased expression of BECN1 was associated with poor survival in HER2+ breast cancer patients; however, no significant association was detected between BRCA1 expression and survival in their study [122]. This evidence concerns the gene ERBB2 and breast carcinoma.